Draft:BioSpring
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed arti
Submission declined on 1 June 2026 by Grapesurgeon (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
 | |
| Type | Private |
|---|---|
| Industry | Pharmaceutical Manufacturing |
| Founded | 1997 |
| Headquarters | Frankfurt a.M, Germany |
| Website | www.biospring.net |
BioSpring is a Contract Manufacturing and Development Organization (CDMO) for Biotech and Pharma companies, specialized in oligonucleotides, and located in Frankfurt a.M. Germany.
History
BioSpring was founded in 1997, by Hüseyin Aygün and Sylvia Wojczewski, then graduate students at Goethe-University-Frankfurt. BioSpring's headquarters are located in Frankfurt-Fechenheim and the company is still privately held and independent. Another production site is currently being built in neighboring Offenbach a.M.[1][2]
The company employs about 600 people with 40 nationalities (as of March 2026). The average employee age is 33 years and half of employees and managers are female.
Products
The active pharmaceutical ingredients, which BioSpring manufactures, serve diverse innovative treatments for formerly untreatable diseases, among others, cardiovascular diseases, metabolic diseases and neuromuscular diseases, and cancer.[3][4][5] The company is specialized in the production and analysis of nucleic acids and specifically oligonucleotides. These molecules, which are short synthetic equivalents of natural genes, are being used in research and development, diagnostics and for therapeutic purposes. BioSpring also manufactures guide RNA for modern gene editing therapies, e.g. CRISPR/Cas9-based treatments. Nuleic acids and oligonucleotides produced by BioSpring:
- Antisense Oligonucleotides (ASO)
- Small interfering RNA (siRNA)
- Guide RNA for genome editing purposes (e.g., CRISPR/Cas9)
- Aptamers
- mRNA
Sources
- ^ "Expansion in Offenbach: 30.000 weitere Quadratmeter für Bio-Spring" (in German). 2022-12-17. Retrieved 2025-01-13.
- ^ "Biotech-Shootingstar Biospring expandiert in Offenbach" (in German). 2022-12-16. Retrieved 2025-01-13.
- ^ "BioSpring hosts event on "Genome Editing – Medicine of the Future" in Frankfurt". Retrieved 2025-01-13.
- ^ "Am Puls der medizinischen Revolution" (in German). 2024-02-09. Retrieved 2025-01-13.
- ^ "BioSpring and Pantherna agree on strategic cooperation in the field of genome editing". Retrieved 2025-01-13.
Category:Companies based in Frankfurt Category:Companies established in 1997 Category:Biotechnology companies
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
- provide significant coverage: discuss the subject in detail, excluding routine coverage like product launches, staff appointments, or financial reports and listings in databases or listicles;
- are reliable: from reputable outlets with editorial oversight;
- are independent: not connected to the subject, such as press releases, the subject's own website, or sponsored content.
Please add references that meet all three of these criteria. If none exist, the subject is not yet suitable for Wikipedia.